·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ñé À¯¸Á Á¦¾à»ç 'º£ÀÌÁ¨', Çѱ¹¹ýÀÎ ¼³¸³ ½ÃÀå ÁøÃâ ±â»çÀÔ·Â : 20.12.08 06:10:43 0 °¡ ÇÃÄ£Ãß°¡ ±¹³» ½ÃÀå °ø·« °¡½ÃÈ¡¦ÁÖ¿ä Àη ä¿ë ÁøÇà ¾ÏÁ¨°ú ÁöºÐ °ü°è¡¦BTKÀúÇØÁ¦ 'ºê·çŲ»ç' µî º¸À¯ [µ¥Àϸ®ÆÊ=¾îÀ±È£ ±âÀÚ] Áß±¹ÀÇ À¯¸Á Á¦¾à»ç 'º£ÀÌÁ¨(BeiGene)'ÀÌ Çѱ¹ ½ÃÀå¿¡ ÁøÃâÇÑ´Ù. °ü·Ã¾÷°è¿¡ µû¸£¸é º£ÀÌÁ¨Àº ÃÖ±Ù Çѱ¹¹ýÀÎÀ» ¼³¸³ÇÏ°í »ç³ëÇÇÁ¨ÀÚÀÓ ÀÇÇкΠÃâ½ÅÀÎ ±èÁöÀ± »ó¹«¸¦ ¿µÀÔÇßÀ¸¸ç ÇöÀç RA(Regulatory Affair: ÀÎÇã°¡), MA(Market Access: ¾à°¡) ´ã´çÀÚ µî ä¿ëÀ» °èȹÇÏ°í ÀÖ´Ù. º£ÀÌÁ¨Àº ±Û·Î¹úÁ¦¾à»ç ¾ÏÁ¨ÀÌ ÁöºÐÀ» º¸À¯ÇÏ°í ÀÖ´Â ¾÷ü´Ù. ¾ÏÁ¨Àº Áö³ÇØ º£ÀÌÁ¨ÀÇ ÁöºÐ 20% °¡·®À» 27¾ï´Þ·¯(¾à 3Á¶1000¾ï¿ø)¿¡ ÀμöÇß´Ù. ÀÌ È¸»ç´Â Áß±¹¿¡¼ ¾ÏÁ¨ÀÇ ´Ù¹ß°ñ¼öÁ¾Ä¡·áÁ¦ 'Å°ÇÁ·Ñ¸®½º(Ä«¸£ÇÊÁ¶¹Ó)', ±Þ¼º¹éÇ÷º´Ä¡·áÁ¦ 'ºí¸°»çÀÌÅä(ºí¸®³ªÅõ¸ð¸¿)' µî 3Á¾ÀÇ ½Å¾àÀ» °ø±ÞÇÏ°í ÀÖ´Ù. ÇÑÆí º£ÀÌÁ¨Àº 'Å°Æ®·ç´Ù(Æèºê·Ñ¸®ÁÖ¸¿)', '¿Éµðº¸(´Ïº¼·ç¸¿)" µî°ú °°Àº PD-1ÀúÇØ ±âÀüÀÇ ¸é¿ªÇ×¾ÏÁ¦ Èĺ¸¹°ÁúÀ» BMS·Î Èí¼öµÈ ¼¼¿¤Áø¿¡ ±â¼ú¼öÃâ, BTKÀúÇØ ±âÀüÀÇ ¿ÜÅõ¼¼Æ÷¸²ÇÁÁ¾Ä¡·áÁ¦ 'ºê·çŲ»ç(ÀÚ´©ºê·çƼ´Õ)'ÀÇ ¹Ì±¹ FDA ½ÂÀÎÀ» ȹµæÇϱ⵵ Çß´Ù. ¾îÀ±È£ ±âÀÚ(unkindfish@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ¾ÏÁ¨, ±¹³»¼ ¾ÆÀϸ®¾Æ ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀÓ»ó3»ó ½ÂÀÎ · 'Ȧ·Î¼±â' Çѱ¹ÈÀÌÀÚ¾÷Á¸, À۳⠸ÅÃâ 3858¾ï¿ø · Çѱ¹ ÁøÃâÇÑ CSLº£¸µ, Ç÷¿ìº´Ä¡·áÁ¦ ½ÃÀå µµÀüÀå [HLBÁ¦¾à] ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Sr. Regional Medical Advisor (MSL) ¹Ù·Î°¡±â ¢ß¾ÖÀÓ½º¹ÙÀÌ¿À»çÀ̾𽺠RA Manager ä¿ë ¹Ù·Î°¡±â RA/QA ÆÀ¿ø °è¾àÁ÷ ä¿ë ¹Ù·Î°¡±â Clinical Research Associate ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) °³¹ßºÎ(ÀǾàÇ° Çмú ¾÷¹«) ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â SM(OPH) MSL (À°ÈÞ´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â ÀǾàÇ°Àç°í ÀÔÃâ°í¹× Àç°í°ü¸®»ç¿ø¸ðÁý ¹Ù·Î°¡±â ¾à»ç(ÀǾàÇ° µµ¸Å¾÷ Ç°Áú°ü¸® Ã¥ÀÓÀÚ) ¸ðÁý ¹Ù·Î°¡±â »ó¹Ý±â ¼ö½Ãä¿ë(°³¹ß±âȹÆÀ/ÀÇÇÐÆÀ/RAÆÀ/Àڱݰø½ÃÆÀ/¿µ¾÷Áö¿øÆÀ) ¹Ù·Î°¡±â MSL / MI / BD / ÀλçÃѹ« / ´ç´¢¸¶ÄÉÆà / Àü½Ã±âȹ / ¾à»ç ¹Ù·Î°¡±â RA/PV Manager (°úÀå±Þ ÀÌ»ó) ¸ðÁý ¹Ù·Î°¡±â (Sr.) Medical & Scientific Relations ¹Ù·Î°¡±â [±¤µ¿Á¦¾à] ÀǾàBDÆÀ °æ·ÂÁ÷¿ø ¸ðÁý ¼·ù ÀüÇü (¾à»ç Àû±Ø ¿ì´ë) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ñé À¯¸Á Á¦¾à»ç º£ÀÌÁ¨, Çѱ¹¹ýÀÎ ¼³¸³ ½ÃÀå ÁøÃâ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ñé À¯¸Á Á¦¾à»ç 'º£ÀÌÁ¨', Çѱ¹¹ýÀÎ ¼³¸³ ½ÃÀå ÁøÃâ ±â»çÀÔ·Â : 20.12.08 06:10:43 0 °¡ ÇÃÄ£Ãß°¡ ±¹³» ½ÃÀå °ø·« °¡½ÃÈ¡¦ÁÖ¿ä Àη ä¿ë ÁøÇà ¾ÏÁ¨°ú ÁöºÐ °ü°è¡¦BTKÀúÇØÁ¦ 'ºê·çŲ»ç' µî º¸À¯ [µ¥Àϸ®ÆÊ=¾îÀ±È£ ±âÀÚ] Áß±¹ÀÇ À¯¸Á Á¦¾à»ç 'º£ÀÌÁ¨(BeiGene)'ÀÌ Çѱ¹ ½ÃÀå¿¡ ÁøÃâÇÑ´Ù. °ü·Ã¾÷°è¿¡ µû¸£¸é º£ÀÌÁ¨Àº ÃÖ±Ù Çѱ¹¹ýÀÎÀ» ¼³¸³ÇÏ°í »ç³ëÇÇÁ¨ÀÚÀÓ ÀÇÇкΠÃâ½ÅÀÎ ±èÁöÀ± »ó¹«¸¦ ¿µÀÔÇßÀ¸¸ç ÇöÀç RA(Regulatory Affair: ÀÎÇã°¡), MA(Market Access: ¾à°¡) ´ã´çÀÚ µî ä¿ëÀ» °èȹÇÏ°í ÀÖ´Ù. º£ÀÌÁ¨Àº ±Û·Î¹úÁ¦¾à»ç ¾ÏÁ¨ÀÌ ÁöºÐÀ» º¸À¯ÇÏ°í ÀÖ´Â ¾÷ü´Ù. ¾ÏÁ¨Àº Áö³ÇØ º£ÀÌÁ¨ÀÇ ÁöºÐ 20% °¡·®À» 27¾ï´Þ·¯(¾à 3Á¶1000¾ï¿ø)¿¡ ÀμöÇß´Ù. ÀÌ È¸»ç´Â Áß±¹¿¡¼ ¾ÏÁ¨ÀÇ ´Ù¹ß°ñ¼öÁ¾Ä¡·áÁ¦ 'Å°ÇÁ·Ñ¸®½º(Ä«¸£ÇÊÁ¶¹Ó)', ±Þ¼º¹éÇ÷º´Ä¡·áÁ¦ 'ºí¸°»çÀÌÅä(ºí¸®³ªÅõ¸ð¸¿)' µî 3Á¾ÀÇ ½Å¾àÀ» °ø±ÞÇÏ°í ÀÖ´Ù. ÇÑÆí º£ÀÌÁ¨Àº 'Å°Æ®·ç´Ù(Æèºê·Ñ¸®ÁÖ¸¿)', '¿Éµðº¸(´Ïº¼·ç¸¿)" µî°ú °°Àº PD-1ÀúÇØ ±âÀüÀÇ ¸é¿ªÇ×¾ÏÁ¦ Èĺ¸¹°ÁúÀ» BMS·Î Èí¼öµÈ ¼¼¿¤Áø¿¡ ±â¼ú¼öÃâ, BTKÀúÇØ ±âÀüÀÇ ¿ÜÅõ¼¼Æ÷¸²ÇÁÁ¾Ä¡·áÁ¦ 'ºê·çŲ»ç(ÀÚ´©ºê·çƼ´Õ)'ÀÇ ¹Ì±¹ FDA ½ÂÀÎÀ» ȹµæÇϱ⵵ Çß´Ù. ¾îÀ±È£ ±âÀÚ(unkindfish@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · ¾ÏÁ¨, ±¹³»¼ ¾ÆÀϸ®¾Æ ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀÓ»ó3»ó ½ÂÀÎ · 'Ȧ·Î¼±â' Çѱ¹ÈÀÌÀÚ¾÷Á¸, À۳⠸ÅÃâ 3858¾ï¿ø · Çѱ¹ ÁøÃâÇÑ CSLº£¸µ, Ç÷¿ìº´Ä¡·áÁ¦ ½ÃÀå µµÀüÀå [HLBÁ¦¾à] ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Sr. Regional Medical Advisor (MSL) ¹Ù·Î°¡±â ¢ß¾ÖÀÓ½º¹ÙÀÌ¿À»çÀ̾𽺠RA Manager ä¿ë ¹Ù·Î°¡±â RA/QA ÆÀ¿ø °è¾àÁ÷ ä¿ë ¹Ù·Î°¡±â Clinical Research Associate ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) °³¹ßºÎ(ÀǾàÇ° Çмú ¾÷¹«) ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â (´ëÀü/Ãæû) ¿µ¾÷ºÎ °æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â SM(OPH) MSL (À°ÈÞ´ëü 1³â °è¾àÁ÷) ¹Ù·Î°¡±â ÀǾàÇ°Àç°í ÀÔÃâ°í¹× Àç°í°ü¸®»ç¿ø¸ðÁý ¹Ù·Î°¡±â ¾à»ç(ÀǾàÇ° µµ¸Å¾÷ Ç°Áú°ü¸® Ã¥ÀÓÀÚ) ¸ðÁý ¹Ù·Î°¡±â »ó¹Ý±â ¼ö½Ãä¿ë(°³¹ß±âȹÆÀ/ÀÇÇÐÆÀ/RAÆÀ/Àڱݰø½ÃÆÀ/¿µ¾÷Áö¿øÆÀ) ¹Ù·Î°¡±â MSL / MI / BD / ÀλçÃѹ« / ´ç´¢¸¶ÄÉÆà / Àü½Ã±âȹ / ¾à»ç ¹Ù·Î°¡±â RA/PV Manager (°úÀå±Þ ÀÌ»ó) ¸ðÁý ¹Ù·Î°¡±â (Sr.) Medical & Scientific Relations ¹Ù·Î°¡±â [±¤µ¿Á¦¾à] ÀǾàBDÆÀ °æ·ÂÁ÷¿ø ¸ðÁý ¼·ù ÀüÇü (¾à»ç Àû±Ø ¿ì´ë) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ñé À¯¸Á Á¦¾à»ç º£ÀÌÁ¨, Çѱ¹¹ýÀÎ ¼³¸³ ½ÃÀå ÁøÃâ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ñé À¯¸Á Á¦¾à»ç 'º£ÀÌÁ¨', Çѱ¹¹ýÀÎ ¼³¸³ ½ÃÀå ÁøÃâ ±â»çÀÔ·Â : 20.12.08 06:10:43 0 °¡ ÇÃÄ£Ãß°¡ ±¹³» ½ÃÀå °ø·« °¡½ÃÈ¡¦ÁÖ¿ä Àη ä¿ë ÁøÇà ¾ÏÁ¨°ú ÁöºÐ °ü°è¡¦BTKÀúÇØÁ¦ 'ºê·çŲ»ç' µî º¸À¯ [µ¥Àϸ®ÆÊ=¾îÀ±È£ ±âÀÚ] Áß±¹ÀÇ À¯¸Á Á¦¾à»ç 'º£ÀÌÁ¨(BeiGene)'ÀÌ Çѱ¹ ½ÃÀå¿¡ ÁøÃâÇÑ´Ù. °ü·Ã¾÷°è¿¡ µû¸£¸é º£ÀÌÁ¨Àº ÃÖ±Ù Çѱ¹¹ýÀÎÀ» ¼³¸³ÇÏ°í »ç³ëÇÇÁ¨ÀÚÀÓ ÀÇÇкΠÃâ½ÅÀÎ ±èÁöÀ± »ó¹«¸¦ ¿µÀÔÇßÀ¸¸ç ÇöÀç RA(Regulatory Affair: ÀÎÇã°¡), MA(Market Access: ¾à°¡) ´ã´çÀÚ µî ä¿ëÀ» °èȹÇÏ°í ÀÖ´Ù. º£ÀÌÁ¨Àº ±Û·Î¹úÁ¦¾à»ç ¾ÏÁ¨ÀÌ ÁöºÐÀ» º¸À¯ÇÏ°í ÀÖ´Â ¾÷ü´Ù. ¾ÏÁ¨Àº Áö³ÇØ º£ÀÌÁ¨ÀÇ ÁöºÐ 20% °¡·®À» 27¾ï´Þ·¯(¾à 3Á¶1000¾ï¿ø)¿¡ ÀμöÇß´Ù. ÀÌ È¸»ç´Â Áß±¹¿¡¼ ¾ÏÁ¨ÀÇ ´Ù¹ß°ñ¼öÁ¾Ä¡·áÁ¦ 'Å°ÇÁ·Ñ¸®½º(Ä«¸£ÇÊÁ¶¹Ó)', ±Þ¼º¹éÇ÷º´Ä¡·áÁ¦ 'ºí¸°»çÀÌÅä(ºí¸®³ªÅõ¸ð¸¿)' µî 3Á¾ÀÇ ½Å¾àÀ» °ø±ÞÇÏ°í ÀÖ´Ù. ÇÑÆí º£ÀÌÁ¨Àº 'Å°Æ®·ç´Ù(Æèºê·Ñ¸®ÁÖ¸¿)', '¿Éµðº¸(´Ïº¼·ç¸¿)" µî°ú °°Àº PD-1ÀúÇØ ±âÀüÀÇ ¸é¿ªÇ×¾ÏÁ¦ Èĺ¸¹°ÁúÀ» BMS·Î Èí¼öµÈ ¼¼¿¤Áø¿¡ ±â¼ú¼öÃâ, BTKÀúÇØ ±âÀüÀÇ ¿ÜÅõ¼¼Æ÷¸²ÇÁÁ¾Ä¡·áÁ¦ 'ºê·çŲ»ç(ÀÚ´©ºê·çƼ´Õ)'ÀÇ ¹Ì±¹ FDA ½ÂÀÎÀ» ȹµæÇϱ⵵ Çß´Ù. ¾îÀ±È£ ±âÀÚ(unkindfish@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
°ü·Ã±â»ç · ¾ÏÁ¨, ±¹³»¼ ¾ÆÀϸ®¾Æ ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀÓ»ó3»ó ½ÂÀÎ · 'Ȧ·Î¼±â' Çѱ¹ÈÀÌÀÚ¾÷Á¸, À۳⠸ÅÃâ 3858¾ï¿ø · Çѱ¹ ÁøÃâÇÑ CSLº£¸µ, Ç÷¿ìº´Ä¡·áÁ¦ ½ÃÀå µµÀüÀå
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ñé À¯¸Á Á¦¾à»ç º£ÀÌÁ¨, Çѱ¹¹ýÀÎ ¼³¸³ ½ÃÀå ÁøÃâ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö